NDC11 00002823301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00002-8233-01 | 00002-8233 |
| 00002-8233-1 | 00002-8233 |
| 0002-8233-01 | 0002-8233 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen | INSULIN LISPRO | Eli Lilly and Company | e49f701d-c19f-4cb2-b63f-01a917b33abc | 2024-08-06 | Warnings, Adverse reactions | 0002-8233-01 0002-8233 00002823301 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.